Ignite Creation Date:
2024-05-06 @ 3:45 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04744363
Status:
COMPLETED
Last Update Posted:
2022-05-23
First Post:
2020-12-16
Brief Title:
Pharmacokinetics Safety and Tolerability Study of AVT04 to EU Approved and US Licensed Stelara Ustekinumab
Sponsor:
Alvotech Swiss AG
Organization:
Alvotech Swiss AG
Organization Data
Organization:
Alvotech Swiss AG
Class:
INDUSTRY
Study ID:
AVT04-GL-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Alvotech Swiss AG
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Iqvia Pty Ltd | INDUSTRY |